136 related articles for article (PubMed ID: 650152)
1. Acute phase reactants ceruloplasmin and haptoglobin and their relationship to plasma prostaglandins in rabbits bearing the VS2 carcinoma.
Voelkel EF; Levine L; Alper CA; Tashjian AH
J Exp Med; 1978 Apr; 147(4):1078-88. PubMed ID: 650152
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentrations of 13,14-dihydro-15-keto-prostaglandin E2 in rabbits bearing the VX2 carcinoma: effects of hydrocortisone and indomethacin.
Tashjian AH; Voelkel EF; Levine L
Prostaglandins; 1977 Aug; 14(2):309-17. PubMed ID: 897222
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcemia and tumor-prostaglandins: the VX2 carcinoma model in the rabbit.
Voelkel EF; Tashjian AH; Franklin R; Wasserman E; Levine L
Metabolism; 1975 Aug; 24(8):973-86. PubMed ID: 1143092
[TBL] [Abstract][Full Text] [Related]
4. Analysis by high performance liquid chromatography of cyclooxygenase products of arachidonic acid metabolism in plasma of rabbits bearing the VX2 carcinoma.
Alam I; Voelkel EF; Tashjian AH; Levine L
Prostaglandins Med; 1980 Apr; 4(4):227-37. PubMed ID: 6771779
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin-mediated hypercalcemia in the VX2 carcinoma-bearing rabbit.
Seyberth HW; Hubbard WC; Oelz O; Sweetman BJ; Watson JT; Oates JA
Prostaglandins; 1977 Aug; 14(2):319-31. PubMed ID: 897223
[TBL] [Abstract][Full Text] [Related]
6. The site of VX2 tumor transplantation affects the development of hypercalcemia in rabbits.
Hubbard WC; Hough AJ; Johnson RM; Oates JA
Prostaglandins; 1980 Jun; 19(6):881-9. PubMed ID: 7384559
[TBL] [Abstract][Full Text] [Related]
7. Gut-mediated hypercalcemia in rabbits bearing VX2 carcinoma: new mechanism for tumor-induced hypercalcemia.
Doppelt SH; Slovik DM; Neer RM; Nolan J; Zusman RM; Potts JT
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):640-4. PubMed ID: 6210910
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of hypercalcemia associated with malignancy: interactions between induction of hypercalcemia and autonomous growth in VX2 cancer cells].
Kato I
Osaka Daigaku Shigaku Zasshi; 1989 Jun; 34(1):142-73. PubMed ID: 2637347
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2, plasma renin activity, and renal function throughout rabbit pregnancy.
Venuto RC; Donker AJ
J Lab Clin Med; 1982 Feb; 99(2):239-46. PubMed ID: 7038009
[TBL] [Abstract][Full Text] [Related]
10. Dietary menhaden oil lowers plasma prostaglandins and calcium in mice bearing the prostaglandin-producing HSDM1 fibrosarcoma.
Tashjian AH; Voelkel EF; Robinson DR; Levine L
J Clin Invest; 1984 Dec; 74(6):2042-8. PubMed ID: 6439740
[TBL] [Abstract][Full Text] [Related]
11. Role of endogenous prostaglandin E2 in erythropoietin production and dome formation by human renal carcinoma cells in culture.
Hagiwara M; McNamara DB; Chen IL; Fisher JW
J Clin Invest; 1984 Oct; 74(4):1252-61. PubMed ID: 6434592
[TBL] [Abstract][Full Text] [Related]
12. The role of prostaglandins E2 and F2 alpha in ultraviolet radiation-induced cortical cataracts in vivo.
Andley UP; Fritz C; Morrison AR; Becker B
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1539-48. PubMed ID: 8675396
[TBL] [Abstract][Full Text] [Related]
13. [Changes in blood levels of haptoglobin and ceruloplasmin in vitamin A deficiency in Sprague-Dawley rats].
Esvant JY; Gobron S; Ruelland A; Legras B; Cloarec L
Ann Nutr Metab; 1983; 27(3):194-8. PubMed ID: 6859810
[TBL] [Abstract][Full Text] [Related]
14. [Haptoglobin and ceruloplasmin in systemic scleroderma].
Volkova ZI; Kaĭnova AS; Balabanova RM
Vopr Med Khim; 1977; (3):294-7. PubMed ID: 888393
[TBL] [Abstract][Full Text] [Related]
15. Absence of prostacyclin involvement in angiotensin-induced aldosterone secretion in rat adrenal cells.
Campbell WB; Gomez-Sanchez CE
Endocrinology; 1985 Jul; 117(1):279-86. PubMed ID: 3924581
[TBL] [Abstract][Full Text] [Related]
16. Control of VX2 carcinoma cell growth in culture by calcium, calmodulin, and prostaglandins.
Yoneda T; Kitamura M; Ogawa T; Aya S; Sakuda M
Cancer Res; 1985 Jan; 45(1):398-405. PubMed ID: 3917374
[TBL] [Abstract][Full Text] [Related]
17. A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics.
Bothwell W; Verburg M; Wynalda M; Daniels EG; Fitzpatrick FA
J Pharmacol Exp Ther; 1982 Feb; 220(2):229-35. PubMed ID: 6948952
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a radioimmunoassay for prostaglandin E2 metabolite levels in plasma.
Demers LM; Brennecke SP; Mountford LA; Brunt JD; Turnbull AC
J Clin Endocrinol Metab; 1983 Jul; 57(1):101-6. PubMed ID: 6853670
[TBL] [Abstract][Full Text] [Related]
19. Development of gamma G, gamma A, gamma M, beta IC-beta IA, C 1 esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, alpha 1-antitrypsin, orosomucoid, beta-lipoprotein, alpha 2-macroglobulin, and prealbumin in the human conceptus.
Gitlin D; Biasucci A
J Clin Invest; 1969 Aug; 48(8):1433-46. PubMed ID: 5796355
[TBL] [Abstract][Full Text] [Related]
20. A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy.
Brenner DE; Harvey HA; Lipton A; Demers L
Cancer; 1982 Feb; 49(3):556-61. PubMed ID: 7059914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
